These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 4061374)

  • 1. Cytotoxic chemotherapy and androgen priming in patients with advanced carcinoma of the prostate. A phase II trial of the Piedmont Oncology Association.
    Muss HB; Case D; Cooper MR; Richards F; Spurr CL; Resnick MI; Zekan P; Nelson EC; Puckett JB; Pope E
    Am J Clin Oncol; 1985 Oct; 8(5):396-400. PubMed ID: 4061374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgen depletion and repletion as a means of potentiating the effect of cytotoxic chemotherapy in advanced prostate cancer.
    Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Simmonds M; Gordon R; Rohner T; Drago J; Wettlaufer J
    J Steroid Biochem; 1987; 27(1-3):551-6. PubMed ID: 3695494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen priming and chemotherapy in advanced prostate cancer: evaluation of determinants of clinical outcome.
    Manni A; Bartholomew M; Caplan R; Boucher A; Santen R; Lipton A; Harvey H; Simmonds M; White-Hershey D; Gordon R
    J Clin Oncol; 1988 Sep; 6(9):1456-66. PubMed ID: 3047336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of cyclophosphamide, vincristine, and dexamethasone in the treatment of androgen-independent prostate carcinoma.
    Daliani DD; Assikis V; Tu SM; Papandreou CN; Pagliaro LC; Holtkamp T; Wang X; Thall PF; Logothetis CJ
    Cancer; 2003 Feb; 97(3):561-7. PubMed ID: 12548597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy of advanced breast cancer. Comparison of dibromodulcitol, doxorubicin, vincristine, and fluoxymesterone to thiotepa, doxorubicin, vinblastine, and fluoxymesterone: an Eastern Cooperative Oncology Group Study.
    Skeel RT; Andersen JW; Tormey DC; Benson AB; Asbury RF; Falkson G
    Cancer; 1989 Oct; 64(7):1393-9. PubMed ID: 2505919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot trial of chemohormonal therapy for metastatic prostate carcinoma.
    Dawson NA; Wilding G; Weiss RB; McLeod DG; Linehan WM; Frank JA; Jacob JL; Gelmann EP
    Cancer; 1992 Jan; 69(1):213-8. PubMed ID: 1727665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormone stimulation and chemotherapy in advanced prostate cancer: interim analysis of an ongoing randomized trial.
    Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Simmonds M; White-Hershey D; Gordon RA; Rohner T; Drago J
    Anticancer Res; 1986; 6(2):309-14. PubMed ID: 3518596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.
    Bracarda S; Tonato M; Rosi P; De Angelis V; Mearini E; Cesaroni S; Fornetti P; Porena M
    Cancer; 2000 Mar; 88(6):1438-44. PubMed ID: 10717628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II trial of cyclophosphamide, methotrexate, 5-fluorouracil, and prednisolone rapidly alternating with doxorubicin and vincristine (CMFP/AV) in advanced breast cancer.
    Rischin D; Bishop JF; Olver IN; Laidlaw CR; Zimet A; Jeal P; Dipell JF
    Am J Clin Oncol; 1992 Oct; 15(5):392-4. PubMed ID: 1524039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen priming and response to chemotherapy in advanced prostatic cancer.
    Manni A; Santen RJ; Boucher AE; Lipton A; Harvey H; Simmonds M; White-Hershey D; Gordon RA; Rohner TJ; Drago J
    J Urol; 1986 Dec; 136(6):1242-6. PubMed ID: 3534315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Adriamycin, cyclophosphamide, vincristine and methotrexate combination chemotherapy of small cell lung cancer].
    Saito H; Kawatsu H; Saka H; Yamamoto M; Takagi E; Tsunekawa H; Kawachi H; Nagura E; Sakai S; Nishiwaki K
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1909-13. PubMed ID: 2838000
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B.
    Aisner J; Weinberg V; Perloff M; Weiss R; Perry M; Korzun A; Ginsberg S; Holland JF
    J Clin Oncol; 1987 Oct; 5(10):1523-33. PubMed ID: 3655855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II trial of oral estramustine, oral etoposide, and intravenous paclitaxel in hormone-refractory prostate cancer.
    Smith DC; Esper P; Strawderman M; Redman B; Pienta KJ
    J Clin Oncol; 1999 Jun; 17(6):1664-71. PubMed ID: 10561202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy with 5-fluorouracil, oral Idarubicin, and cyclophosphamide (FIC) in metastatic breast cancer--an open phase II study.
    Kolarić K; Potrebica V; Vukas D; Mechl Z; Sopkova B
    J Cancer Res Clin Oncol; 1988; 114(3):301-5. PubMed ID: 3164312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Value of cyclophosphamide or melphalan as combined chemotherapy in hormonally unresponsive prostatic carcinoma.
    Graham SD; Walker A; Cox EB; Laszlo J; Berry WR; Paulson DF
    Urology; 1986 Nov; 28(5):404-8. PubMed ID: 3538611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclophosphamide, methotrexate, and 5-fluorouracil in the treatment of metastatic prostate cancer. A Southwest Oncology Group study.
    Wozniak AJ; Blumenstein BA; Crawford ED; Boileau M; Rivkin SE; Fletcher WS
    Cancer; 1993 Jun; 71(12):3975-8. PubMed ID: 8508363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination chemotherapy for metastatic or recurrent carcinoma of the breast--a randomized phase III trial comparing CAF versus VATH versus VATH alternating with CMFVP: Cancer and Leukemia Group B Study 8281.
    Aisner J; Cirrincione C; Perloff M; Perry M; Budman D; Abrams J; Panasci L; Muss H; Citron M; Holland J
    J Clin Oncol; 1995 Jun; 13(6):1443-52. PubMed ID: 7751891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclophosphamide versus cyclophosphamide, methotrexate, and 5-fluorouracil in advanced prostatic cancer: a randomized trial.
    Muss HB; Howard V; Richards F; White DR; Jackson DV; Cooper MR; Stuart JJ; Resnick MI; Brodkin R; Spurr CL
    Cancer; 1981 Apr; 47(8):1949-53. PubMed ID: 7194733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination chemotherapy with prednimustine, adriamycin, vincristine (VAP) in advanced breast cancer. A phase II study.
    Kosmidis PA; Fountzilas G; Athanassiou A; Karabelis A; Mylonakis N; Tsavaris N; Karvounis N; Bacojiannis C
    Chemioterapia; 1987 Dec; 6(6):393-5. PubMed ID: 3435921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I trial of interferon-alpha-2a plus cyclophosphamide, vincristine, prednisone, and doxorubicin.
    Schiller JH; Hawkins MJ; O'Connell MJ; Sielaff K; Borden EC
    J Biol Response Mod; 1989 Jun; 8(3):252-61. PubMed ID: 2746297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.